Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat

被引:140
作者
Williamson, DJ [1 ]
Hargreaves, RJ [1 ]
Hill, RG [1 ]
Shepheard, SL [1 ]
机构
[1] MERCK SHARP & DOHME RES LABS,DEPT PHARMACOL,NEUROSCI RES CTR,HARLOW,ESSEX,ENGLAND
关键词
substance P; CGRP; vasodilation; migraine;
D O I
10.1046/j.1468-2982.1997.1704518.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study describes a novel intravital microscope technique for direct measurement of dural blood vessel diameter through a closed cranial window in anaesthetized rats. This technique avoids removal of the skull, which can lead to problems of altered vessel reactivity and brain swelling that are encountered with open cranial window techniques. Substance P and calcitonin gene-related (CGRP) evoked increases in dural vessel diameter, which were abolished by the NK1 receptor antagonist, RP67580 and the CGRP receptor antagonist, human-alpha CGRP((8-37)) respectively Neurokinin A produced increases in dural vessel diameter which were unaffected by the NK2 receptor antagonist SR 48968 but were blocked by RP67580 suggesting that neurokinin A can act through NK1 receptors to produce dural vasodilation in rats. The NK3 receptor agonist, senktide, had no effects on dural vessel diameter. All drugs were administered intravenously. In humans, vasodilation within the meningeal vasculature has been implicated in the pathogenesis of migraine, the present experiments indicate that substance P or neurokinin A (both acting through NK1 receptors) or CGRP may be responsible.
引用
收藏
页码:518 / 524
页数:7
相关论文
共 29 条
[1]   NEUROKININ A (NK2) RECEPTOR REVISITED WITH SR-48968, A POTENT NONPEPTIDE ANTAGONIST [J].
ADVENIER, C ;
ROUISSI, N ;
NGUYEN, QT ;
EMONDSALT, X ;
BRELIERE, JC ;
NELIAT, G ;
NALINE, E ;
REGOLI, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (03) :1418-1424
[2]   NEUROKININ-INDUCED CHANGES IN PIAL ARTERY DIAMETER IN THE ANESTHETIZED GUINEA-PIG [J].
BEATTIE, DT ;
STUBBS, CM ;
CONNOR, HE ;
FENIUK, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (01) :146-149
[3]  
CASCIERI MA, 1992, MOL PHARMACOL, V41, P1096
[4]   CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONIST HUMAN CGRP-(8-37) [J].
CHIBA, T ;
YAMAGUCHI, A ;
YAMATANI, T ;
NAKAMURA, A ;
MORISHITA, T ;
INUI, T ;
FUKASE, M ;
NODA, T ;
FUJITA, T .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (02) :E331-E335
[5]   RELATIVE INVOLVEMENT OF SUBSTANCE-P AND CGRP MECHANISMS IN ANTIDROMIC VASODILATION IN THE RAT SKIN [J].
DELAYGOYET, P ;
SATOH, H ;
LUNDBERG, JM .
ACTA PHYSIOLOGICA SCANDINAVICA, 1992, 146 (04) :537-538
[6]  
EDVINSSON L, 1991, BLOOD VESSELS, V28, P35
[7]   RETROGRADE TRACING OF NERVE-FIBERS TO THE RAT MIDDLE CEREBRAL-ARTERY WITH TRUE BLUE - COLOCALIZATION WITH DIFFERENT PEPTIDES [J].
EDVINSSON, L ;
HARA, H ;
UDDMAN, R .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1989, 9 (02) :212-218
[8]   MODIFICATION OF VASOCONSTRICTOR RESPONSES IN CEREBRAL BLOOD-VESSELS BY LESIONING OF THE TRIGEMINAL NERVE - POSSIBLE INVOLVEMENT OF CGRP [J].
EDVINSSON, L ;
OLESEN, IJ ;
KINGMAN, TA ;
MCCULLOCH, J ;
UDDMAN, R .
CEPHALALGIA, 1995, 15 (05) :373-383
[9]   THE INVOLVEMENT OF CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AND SUBSTANCE-P IN FELINE PIAL ARTERY DIAMETER RESPONSES EVOKED BY CAPSAICIN [J].
ESCOTT, KJ ;
CONNOR, HE ;
BRAIN, SD ;
BEATTIE, DT .
NEUROPEPTIDES, 1995, 29 (03) :129-135
[10]   VASOACTIVE PEPTIDE LEVELS IN THE PLASMA OF YOUNG MIGRAINE PATIENTS WITH AND WITHOUT AURA ASSESSED BOTH INTERICTALLY AND ICTALLY [J].
GALLAI, V ;
SARCHIELLI, P ;
FLORIDI, A ;
FRANCESCHINI, M ;
CODINI, M ;
GLIOTI, G ;
TREQUATTRINI, A ;
PALUMBO, R .
CEPHALALGIA, 1995, 15 (05) :384-390